title: [Acute coronary syndromes with ST elevation and angiographically normal culprit coronary arteries: Case report and update].
abstract: Acute coronary syndrome results in most cases of atherosclerotic plaque rupture. In a few cases, the physiopathological mechanism is different. This does not necessarily change the initial strategy but the subsequent treatments. We report three cases of clinical presentations of acute coronary syndrome whose pathophysiological mechanism is not or not mainly due to atherosclerotic lesions. Based on these cases and a review of the literature, two topics will be tackled: the diagnostic and therapeutic strategy in the management of Tako-tsubo cardiomyopathies and also acute coronary syndromes due to vasospastic angina.
authors.affiliation: Service de cardiologie, hôpital Foch, 40, rue Worth, 92150 Suresnes, France; Service de cardiologie, centre hospitalier universitaire Bichat - Claude-Bernard, 46, rue Henri-Huchard, 75018 Paris, France; Service de cardiologie, centre hospitalier régional d'Orléans, 14, avenue de l'Hôpital, 45067 Orléans, France. Electronic address: xdufretay@wanadoo.fr.
authors.forename: X
authors.initials: X
authors.lastname: Halna du Fretay
authors.affiliation: Service de cardiologie, centre hospitalier régional d'Orléans, 14, avenue de l'Hôpital, 45067 Orléans, France.
authors.forename: O
authors.initials: O
authors.lastname: Dibon
authors.affiliation: Service de cardiologie, centre hospitalier régional d'Orléans, 14, avenue de l'Hôpital, 45067 Orléans, France.
authors.forename: J
authors.initials: J
authors.lastname: Naël
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D000369:Aged, 80 and over; D000701:Analgesics, Opioid / Q000008:administration & dosage; D017130:Angioplasty / Q000379:methods; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage; D000925:Anticoagulants / Q000008:administration & dosage; D050197:Atherosclerosis / Q000150:complications; D017023:Coronary Angiography; D003329:Coronary Vasospasm / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D004562:Electrocardiography; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D054549:Takotsubo Cardiomyopathy / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Acute coronary syndrome; Angor spastique; Coronary spasm provocation test; Syndrome coronarien aigu; Tako-tsubo; Test de provocation du spasme coronaire; Vasospastic angina